Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

BactiQuant udsteder warrants til selskabets direktion og medarbejdere

BACTIQRegulatory press release23.09.2026, 14.15
Download the release

23.9.2026 14:15:28 CEST | BactiQuant A/S | Selskabsmeddelelse

INTERN VIDEN

Bestyrelsen har besluttet at udstede warrants til Selskabets direktion og medarbejdere.

Tildelingen af warrants sker på baggrund af en bemyndigelse til bestyrelsen og i overensstemmelse med § 5.4 i selskabets vedtægter.

Det samlede antal warrants, der tildeles Selskabets direktion og medarbejdere, udgør i alt 1.247.500 warrants, der giver ret til at tegne 1.247.500 aktier i Selskabet svarende til 3,324 % af Selskabets samlede selskabskapital.

Udnyttelseskursen udgør DKK 2,186 per warrant, hvilket svarer til markedskursen beregnet som 10 dages vægtet gennemsnit.

Udstedelsen af warrants sker som en engangsudstedelse og på vilkår, der fastsættes af bestyrelsen, således at modning sker med 1/36 om måneden i perioden fra 1. december 2026 til og med 1. december 2029. Modning er betinget af modtagerens fortsatte ansættelse i Selskabet på modningstidspunktet.

Warrantmodtageren skal ikke betale vederlag for at tegne warrants, og de kan udnyttes fra den 1. januar 2030 og indtil 60 måneder herefter. Warrants, der ikke er udnyttet efter de 60 måneder, bortfalder.

BactiQuant A/S’ aktiekapital udgør p.t. nominelt 1.876.092,80 kr. fordelt på 37.521.856 aktier a DKK 0,05.

BactiQuant vil offentliggøre selskabets opdaterede vedtægter på sin hjemmeside.

Regulatorisk meddelelse:
Denne meddelelse indeholder intern viden i henhold til Europa-Parlamentets og Rådets Forordning (EU) nr. 596/2014 om markedsmisbrug (Market Abuse Regulation – MAR), artikel 17.

Kontakter

  • Henrik Enegaard Skaanderup, Bestyrelsesformand, +4540334470, henrik-skaanderup@mail.dk
  • John Norden, Certificeret rådgiver til Nasdaq First North, +4520700200, jn@nordencef.dk
  • Morten Miller, Chief Executive Officer CEO, BactiQuant AS, +4523678732, miller@bactiquant.dk

Om BactiQuant A/S

Bactiquant has developed a technology that will revolutionize the monitoring of bacterial contamination levels in water and ensure optimum usage and handling of water around the world to the benefit of our customers and the sustainability of our planet. To show our environmental commitment, we have aligned our business with four of the UN's Sustainable Development Goals. We believe that Bactiquant will be the world leader within mobile and online surveillance of bacterial contamination levels, and we are already well on our way. Headquartered in Denmark and operating across five continents, our customers come from a wide range of industries such as public water utility companies, industries needing water cooling or requiring wastewater treatment, and aquaculture.

Vedhæftninger

  • Download selskabsmeddelelse.pdf